Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11317584 | PMC |
| http://dx.doi.org/10.1073/pnas.2411465121 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Author's Reply to ''Comment on 'Prognostic and Clinical Significance of Human Leukocyte Antigen Class I Expression in Breast Cancer: A Meta-Analysis''.
Mol Diagn Ther
January 2025
Department of Breast Surgery, The First Affiliated Hospital, and College of Clinical Medicine of Henan University of Science and Technology, Jinghua Road No. 24, Luoyang, 471000, China.
Reply to: Comment on the Definition and Interpretation of Complete Mesocolic Excision in the RELARC Trial.
J Clin Oncol
December 2024
Jun-Yang Lu, MD and Yi Xiao, MD, Division of Colorectal Surgery, Department of Surgery, Peking Union Medical College Hospital, Beijing, China.
Reply to: "Rheumatic adverse events associated with biologic therapy for chronic rhinosinusitis: A systematic review and meta-analysis".
Int Forum Allergy Rhinol
January 2025
Department of Otolaryngology-Head & Neck Surgery, University of Toronto, Toronto, Canada.
[Retracted] SET and MYND domain‑containing protein 3 is overexpressed in human glioma and contributes to tumorigenicity.
Oncol Rep
December 2024
Department of Neurosurgery, Beijing Tian Tan Hospital, Capital Medical University, China National Clinical Research Center for Neurological Diseases, Beijing 100050, P.R. China.
Following the publication of this paper, it was drawn to the Editor's attention by a concerned reader that certain of the colony formation assay data featured in Fig. 4A and C on p. 2726, tumor images in Fig.
View Article and Find Full Text PDF[Retracted] Tetramethylpyrazine inhibits prostate cancer progression by downregulation of forkhead box M1.
Oncol Rep
November 2024
Department of Pathology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing 100000, P.R. China.
Following the publication of this paper, it was drawn to the Editor's attention by a concerned reader that certain of the Transwell invasion assay data shown in Fig. 3B on p. 839 were strikingly similar to data that had already appeared in another article written by different authors at different research institutes [Mao Y, Zhang L, Yuan L, Yan M and He Y: MiR‑218 suppresses cell progression by targeting APC in cervical cancer.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!